Current situation of lipoprotein apheresis in Saxony

Schettler, 2012, Current view: indications for extracorporeal lipid apheresis treatment, Clin Res Cardiol Suppl, 7, 15, 10.1007/s11789-012-0046-6 Heigl, 2009, Indication and implementation of lipidapheresis, rheopheresis, or immunoadsorption (lessons learnt from Germany's largest apheresis center), Atheroscler Suppl, 10, 137, 10.1016/S1567-5688(09)71829-X Julius, 2009, The Dresden Apheresis Center – experience with LDL apheresis and immunoadsorption, Atheroscler Suppl, 10, 12, 10.1016/S1567-5688(09)71803-3 Julius, 2008, Comparison of different LDL apheresis methods, Expert Rev Cardiovasc Ther, 6, 629, 10.1586/14779072.6.5.629 Drager, 1998, DALI-the first human whole-blood low-density lipoprotein and lipoprotein(a) apheresis system in clinical use: procedure and clinical results, Eur J Clin Invest, 28, 994, 10.1046/j.1365-2362.1998.00395.x Armstrong, 1994, Heparin extracorporeal LDL precipitation (HELP): an effective apheresis procedure for lowering Lp(a) levels, Chem Phys Lipids, 67–68, 315, 10.1016/0009-3084(94)90152-X Seidel, 1996, H.E.L.P. apheresis therapy in the treatment of severe hypercholesterolemia: 10 years of clinical experience, Artif Organs, 20, 303, 10.1111/j.1525-1594.1996.tb04449.x Julius, 2007, Dextran-sulfate-adsorption of atherosclerotic lipoproteins from whole blood or separated plasma for lipid-apheresis – comparison of performance characteristics with DALI and lipidfiltration, J Clin Apher, 22, 215, 10.1002/jca.20135 Klingel, 2004, Lipidfiltration – safe and effective methodology to perform lipid-apheresis, Transfus Apher Sci, 30, 245, 10.1016/j.transci.2004.01.008 Richter, 1993, Three-year treatment of familial heterozygous hypercholesterolemia by extracorporeal low-density lipoprotein immunoadsorption with polyclonal apolipoprotein B antibodies, Metabolism, 42, 888, 10.1016/0026-0495(93)90065-V Julius, 2010, Lipid apheresis after heart transplantation – the Dresden experience, Transplantationsmedizin, 22, 355 Kroon, 2000, The rebound of lipoproteins after LDL-apheresis. Kinetics and estimation of mean lipoprotein levels, Atherosclerosis, 152, 519, 10.1016/S0021-9150(00)00371-3 Thompson, 2010, Efficacy criteria and cholesterol targets for LDL apheresis, Atherosclerosis, 208, 317, 10.1016/j.atherosclerosis.2009.06.010 Bruckenberger, 2011, vol. 23 Julius U, Fischer S, Schatz U, Passauer J, Bornstein SR. Why an apheresis center should offer more than one lipoprotein apheresis method. Therapeutic Apheresis and Dialysis, in press. Stefanutti, 2013, Lipoprotein apheresis: state of the art and novelties, Atheroscler Suppl, 14, 19, 10.1016/j.atherosclerosissup.2012.10.021